DE69905384D1 - Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs - Google Patents

Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs

Info

Publication number
DE69905384D1
DE69905384D1 DE69905384T DE69905384T DE69905384D1 DE 69905384 D1 DE69905384 D1 DE 69905384D1 DE 69905384 T DE69905384 T DE 69905384T DE 69905384 T DE69905384 T DE 69905384T DE 69905384 D1 DE69905384 D1 DE 69905384D1
Authority
DE
Germany
Prior art keywords
treating
fermented
laxans
colorectal cancer
preventing colorectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69905384T
Other languages
English (en)
Other versions
DE69905384T2 (de
Inventor
E Corpet
Sylviane Tache
Geraldine Parnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
ENVT TOULOUSE
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9813450A external-priority patent/FR2784896B1/fr
Application filed by ENVT TOULOUSE, Institut National de la Recherche Agronomique INRA filed Critical ENVT TOULOUSE
Publication of DE69905384D1 publication Critical patent/DE69905384D1/de
Application granted granted Critical
Publication of DE69905384T2 publication Critical patent/DE69905384T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69905384T 1998-10-27 1999-05-05 Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs Expired - Lifetime DE69905384T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9813450A FR2784896B1 (fr) 1998-10-27 1998-10-27 Utilisation du polyethylene-glycol dans le traitement et la prevention des cancers colorectaux
FR9903240A FR2784897B1 (fr) 1998-10-27 1999-03-16 Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
PCT/FR1999/001065 WO2000024407A1 (fr) 1998-10-27 1999-05-05 Laxatif osmotique non fermente pour traiter et prevenir les cancers colorectaux

Publications (2)

Publication Number Publication Date
DE69905384D1 true DE69905384D1 (de) 2003-03-20
DE69905384T2 DE69905384T2 (de) 2003-11-27

Family

ID=26234618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905384T Expired - Lifetime DE69905384T2 (de) 1998-10-27 1999-05-05 Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs

Country Status (13)

Country Link
US (1) US6939563B2 (de)
EP (1) EP1124566B1 (de)
AT (1) ATE232390T1 (de)
AU (1) AU758348B2 (de)
BR (1) BR9914794A (de)
CA (1) CA2347170C (de)
DE (1) DE69905384T2 (de)
DK (1) DK1124566T3 (de)
ES (1) ES2192840T3 (de)
FR (1) FR2784897B1 (de)
NZ (1) NZ511150A (de)
PT (1) PT1124566E (de)
WO (1) WO2000024407A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE477790T1 (de) * 2001-10-29 2010-09-15 Ajinomoto Kk Lösung zur darmreinigung
WO2006073430A2 (en) * 2004-04-20 2006-07-13 The University Of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9198847B2 (en) * 2004-11-05 2015-12-01 The Procter & Gamble Company Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system
CA2607250C (en) * 2005-05-06 2012-11-06 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
US20090252702A1 (en) * 2006-04-24 2009-10-08 Bruce Medical Ab Polymer-based anti-cancer agents
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
GB201018650D0 (en) * 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
EP3137167A4 (de) 2014-04-29 2017-12-20 Colonaryconcepts LLC Nahrungsmittel systeme, verfahren und kits für elektrolytersatz
AU2016226380A1 (en) 2015-03-02 2017-09-21 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays
EP3934663A1 (de) * 2019-03-05 2022-01-12 Dow Global Technologies LLC Polyethylenglycolderivate zur induktion der caspase-aktivität

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물

Also Published As

Publication number Publication date
DE69905384T2 (de) 2003-11-27
FR2784897B1 (fr) 2002-11-29
WO2000024407A1 (fr) 2000-05-04
AU3528399A (en) 2000-05-15
NZ511150A (en) 2003-03-28
FR2784897A1 (fr) 2000-04-28
CA2347170C (fr) 2011-09-20
EP1124566A1 (de) 2001-08-22
BR9914794A (pt) 2001-07-10
EP1124566B1 (de) 2003-02-12
CA2347170A1 (fr) 2000-05-04
AU758348B2 (en) 2003-03-20
ATE232390T1 (de) 2003-02-15
US20010051659A1 (en) 2001-12-13
ES2192840T3 (es) 2003-10-16
PT1124566E (pt) 2003-06-30
DK1124566T3 (da) 2003-06-02
US6939563B2 (en) 2005-09-06

Similar Documents

Publication Publication Date Title
NO20014662L (no) Fremgangsmåter og preparater for behandling av faste tumorer
DE69905384D1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
IS6647A (is) Kínasólínafleiður til að meðhöndla æxli
ATE430573T1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
DE69127175D1 (de) Antisens-Oligonukleotide zur Behandlung von Krebs
DE69634776D1 (de) Verwendung eines r-nsaid als chemoschützendes mittel zur behandlung kolorektales krebs
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
PT1235571E (pt) Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE299025T1 (de) Pharmazeutische zubereitung enthaltend zytostatika und elektronenakzeptoren zur behandlung von krebs
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
EA200000568A3 (ru) Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы
ATE235909T1 (de) Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
LT99030A (en) Drug plant composition for treatment of hemorrhoid and constipation
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (I.N

R081 Change of applicant/patentee

Ref document number: 1124566

Country of ref document: EP

Owner name: NORGINE B.V., NL

Free format text: FORMER OWNER: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (I.N.R.A.), PARIS, FR

Effective date: 20110620

R082 Change of representative

Ref document number: 1124566

Country of ref document: EP

Representative=s name: BOEHMERT & BOEHMERT, 80336 MUENCHEN, DE